Literature DB >> 6406542

Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.

R L Garlick, J S Mazer, P J Higgins, H F Bunn.   

Abstract

Boronate affinity chromatography and ion exchange chromatography were used to measure the levels of glycosylated hemoglobins in normal and diabetic hemolysates, as well as the distribution of glucose adducts on alpha-NH2-valine and epsilon-NH2-lysine residues. When analyzed by ion exchange chromatography on BioRex 70 resin, the Hb Alc peak comprised 4.4 +/- 0.6% of 15 normal hemolysates and 9.1 +/- 2.1% of 15 diabetic hemolysates. The "Hb Alc" was rechromatographed on GlycoGel B boronate affinity resin that binds vicinal hydroxyl groups of covalently linked sugars. Only 70 +/- 5% of the hemoglobin adhered to the resin. Analysis by the thiobarbituric acid colorimetric test confirmed that the affinity resin effectively separated glycosylated from nonglycosylated hemoglobin. When corrected for nonglycosylated contaminants, the mean level of Hb Alc in normal hemolysates was 2.9 +/- 0.4%, a value considerably lower than those previously reported. In addition to Hb Alc, 5.2 +/- 0.5% of the remaining hemoglobin (Hb Ao) was glycosylated. In diabetics, glycosylated Ao was increased in parallel with Hb Alc. After reduction with [3H]borohydride and acid hydrolysis, glycosylated amino acids were first purified on Affi-Gel boronate affinity resin and then analyzed by ion exchange chromatography. The glucose adducts on Hb Ao were distributed as follows: alpha-chain N-terminal valine, 14%; alpha-chain lysines, 40%; beta-chain lysines, 46%. This study has revealed several pitfalls in the analysis of nonenzymatically glycosylated proteins. Peaks isolated by ion exchange chromatography or electrophoresis are likely to be contaminated by nonglycosylated proteins. Furthermore, both the thiobarbituric acid test and [3H]borohydride reduction show variable reactivity depending upon the site of the ketoamine-linked glucose.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406542      PMCID: PMC436967          DOI: 10.1172/jci110856

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c.

Authors:  H F Bunn; D N Haney; K H Gabbay; P M Gallop
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

2.  In vitro synthesis of hemoglobin AIc.

Authors:  R Flückiger; K H Winterhalter
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

3.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.

Authors:  R J Koenig; C M Peterson; R L Jones; C Saudek; M Lehrman; A Cerami
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

4.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.

Authors:  H F Bunn; D N Haney; S Kamin; K H Gabbay; P M Gallop
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

5.  Fast hemoglobin in lead poisoning.

Authors:  S Charache; D J Weatherall
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

6.  Abnormal human haemoglobins. Separation and characterization of the alpha and beta chains by chromatography, and the determination of two new variants, hb Chesapeak and hb J (Bangkok).

Authors:  J B Clegg; M A Naughton; D J Weatherball
Journal:  J Mol Biol       Date:  1966-08       Impact factor: 5.469

7.  A new N-terminal blocking group involving a Schiff base in hemoglobin AIc.

Authors:  W R Holmquist; W A Schroeder
Journal:  Biochemistry       Date:  1966-08       Impact factor: 3.162

8.  Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.

Authors:  J F Fitzgibbons; R D Koler; R T Jones
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Hemoglobin AIc levels in insulin-dependent and -independent diabetes mellitus.

Authors:  E P Paulsen; M Koury
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

10.  Structure of carbohydrate of hemoglobin AIc.

Authors:  R J Koenig; S H Blobstein; A Cerami
Journal:  J Biol Chem       Date:  1977-05-10       Impact factor: 5.157

View more
  20 in total

1.  ATP-dependent mechanism protects spectrin against glycation in human erythrocytes.

Authors:  Sumie Manno; Narla Mohandas; Yuichi Takakuwa
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

2.  Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.

Authors:  Eric P Smith; Robert M Cohen
Journal:  J Diabetes Sci Technol       Date:  2015-02-17

3.  Crystallin composition of human cataractous lens may be modulated by protein glycation.

Authors:  J Ramalho; C Marques; P Pereira; M C Mota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.

Authors:  Ian Goodall
Journal:  Clin Biochem Rev       Date:  2005-02

5.  Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.

Authors:  J F Poduslo; G L Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

6.  D-Ribosylated Tau forms globular aggregates with high cytotoxicity.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  Cell Mol Life Sci       Date:  2009-06-11       Impact factor: 9.261

7.  Nonenzymatic glycation of human lens crystallin. Effect of aging and diabetes mellitus.

Authors:  R L Garlick; J S Mazer; L T Chylack; W H Tung; H F Bunn
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.

Authors:  Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

9.  Mass spectrometric analysis of N-carboxymethylamino acids as periodate oxidation derivatives of Amadori compounds application to glycosylated haemoglobin.

Authors:  R Badoud; L B Fay
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

10.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.

Authors:  R Zatz; T W Meyer; H G Rennke; B M Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.